Fatal Disease Drug in Limbo TheScientist, November 27, 2015 Fatal Disease Drug in Limbo By Jef Akst A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy. enlace | ampliar ↧ | reducir ↥ | | ampliar ↧ | reducir ↥ |
